MeSH term
Frequency | Condition_Probility | English Abstract | 2 | 0.0 |
Humans | 62 | 0.0 |
Animals | 26 | 0.0 |
*Biosensing Techniques | 4 | 14.0 |
Protein Kinase C/physiology | 2 | 1.0 |
Rats | 11 | 0.0 |
Surface Plasmon Resonance/*methods | 6 | 66.0 |
Amino Acid Sequence | 12 | 0.0 |
Cloning, Molecular | 6 | 0.0 |
Escherichia coli/metabolism | 2 | 0.0 |
Immunoblotting | 2 | 0.0 |
Kinetics | 9 | 0.0 |
Molecular Sequence Data | 13 | 0.0 |
Mutagenesis, Site-Directed | 3 | 0.0 |
Phosphorylation | 6 | 0.0 |
Research Support, Non-U.S. Gov't | 44 | 0.0 |
Cattle | 4 | 0.0 |
Female | 15 | 0.0 |
In Vitro | 3 | 0.0 |
Male | 17 | 0.0 |
Surface Plasmon Resonance | 6 | 3.0 |
Comparative Study | 12 | 0.0 |
Prospective Studies | 2 | 0.0 |
Visual Acuity | 2 | 1.0 |
Protein Conformation | 2 | 0.0 |
Protein Binding | 7 | 0.0 |
*Surface Plasmon Resonance | 4 | 66.0 |
Surface Properties | 5 | 2.0 |
Biosensing Techniques | 3 | 5.0 |
Signal Transduction | 2 | 0.0 |
Time Factors | 5 | 0.0 |
Adult | 12 | 0.0 |
Models, Molecular | 3 | 0.0 |
Alcohol Oxidoreductases/*genetics | 2 | 9.0 |
Blotting, Western | 2 | 0.0 |
Exons | 3 | 0.0 |
Fibroblasts/metabolism | 2 | 0.0 |
Heterozygote | 2 | 0.0 |
*Mutation | 2 | 0.0 |
Polymerase Chain Reaction | 3 | 0.0 |
Skin/metabolism | 2 | 1.0 |
Research Support, U.S. Gov't, P.H.S. | 15 | 0.0 |
CHO Cells | 4 | 0.0 |
Hamsters | 4 | 0.0 |
Phosphotyrosine/*metabolism | 2 | 3.0 |
Signal Transduction/*drug effects | 2 | 0.0 |
Evaluation Studies | 3 | 0.0 |
Plasma | 2 | 3.0 |
Antibodies/metabolism | 2 | 2.0 |
Binding, Competitive | 4 | 0.0 |
Enzyme-Linked Immunosorbent Assay | 2 | 0.0 |
Epitope Mapping | 2 | 0.0 |
Cell Count | 2 | 0.0 |
Consensus Sequence | 2 | 0.0 |
Sequence Homology, Amino Acid | 4 | 0.0 |
Tumor Cells, Cultured | 4 | 0.0 |
Binding Sites | 3 | 0.0 |
Substance P/metabolism | 2 | 3.0 |
Transfection | 7 | 0.0 |
Immunohistochemistry | 3 | 0.0 |
Rats, Wistar | 2 | 0.0 |
Cell Line | 5 | 0.0 |
Substance P/pharmacology | 2 | 6.0 |
Antigen-Antibody Reactions | 2 | 0.0 |
Immunoglobulin G/immunology | 2 | 0.0 |
Mice | 5 | 0.0 |
Biopsy | 2 | 0.0 |
Middle Aged | 7 | 0.0 |
Base Sequence | 5 | 0.0 |
Chromosome Mapping | 3 | 0.0 |
Genomic Library | 2 | 0.0 |
Restriction Mapping | 3 | 0.0 |
Aged | 5 | 0.0 |
Cell Adhesion | 2 | 0.0 |
HLA-DR Antigens/analysis | 2 | 0.0 |
Intercellular Adhesion Molecule-1/analysis | 2 | 1.0 |
Recombinant Proteins/metabolism | 3 | 0.0 |
Research Support, U.S. Gov't, Non-P.H.S. | 5 | 0.0 |
Aged, 80 and over | 2 | 0.0 |
Sensitivity and Specificity | 4 | 0.0 |
Analysis of Variance | 3 | 0.0 |
Reproducibility of Results | 3 | 0.0 |
Adolescent | 2 | 0.0 |
Behcet Syndrome/*immunology/pathology | 2 | 28.0 |
Cell Adhesion Molecules/analysis | 2 | 1.0 |
Skin/*immunology | 2 | 1.0 |
Skin Tests | 2 | 1.0 |
Fluorescent Dyes | 2 | 0.0 |
Amino Acid Motifs | 2 | 0.0 |
Protein Structure, Tertiary | 3 | 0.0 |
Blotting, Southern | 3 | 0.0 |
DNA, Complementary | 2 | 0.0 |
Receptors, Neurokinin-1 | 5 | 71.0 |
Recombinant Proteins/biosynthesis | 2 | 0.0 |
RNA, Messenger/genetics | 2 | 0.0 |
Sequence Homology, Nucleic Acid | 3 | 0.0 |
